Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a review found.

Harald Stover, Ph.D., Founder and CEO, Allarta Life Science; Professor of Chemistry and Chemical Biology, McMaster University ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in two trials.

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The ...

Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of ...

An East Yorkshire woman has recalled the moment her life changed when she sat in a GP waiting room with her three-year-old brother while her mum was told she had cancer.

The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 million, above estimates of $324 million. Quarterly sales of J&J's cancer drugs ...

Sickle cell disease, characterised by the abnormal sickle shape of red blood cells instead of the typical round form, is the UK's most rapidly expanding genetic disorder. This deformation causes ...